Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leyvraz

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Revue Medicale Suisse|July 12, 2008
[New developments in cancer immunotherapy]O Michielin, N Rufer, P Romero, et al.
Acta Neurochirurgica|February 14, 2004
The origin of brain metastases in patients with an undiagnosed primary tumourS Agazzi, S Pampallona, A Pica, et al.
British Journal of Cancer|August 31, 2006
CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase IIV Voelter, A Zouhair, H Vuilleumier, et al.
Journal of the National Cancer Institute|December 1, 1993
Sequential high-dose combination chemotherapy with granulocyte colony-stimulating factor and peripheral blood progenitor cells in patients with solid tumors: intensification limited by nonhematologic toxic effectsS Leyvraz, N Ketterer, P Vuichard, et al.
Psycho-Oncology|August 29, 2013
Psychodynamic interventions in cancer care I: psychometric results of a randomized controlled trialG Ludwig, S Krenz, C Zdrojewski, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administrationC Marzolini, L A Decosterd, F Shen, et al.
The New England Journal of Medicine|May 16, 1985
Association of Epstein-Barr virus with thymic carcinomaS Leyvraz, W Henle, A P Chahinian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomasS Leyvraz, M Zweifel, G Jundt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 6, 2007
Impact of family structure on long-term survivors of osteosarcomaA Bressoud, O Real del Sarte, S Stiefel, et al.
Revue Medicale Suisse|July 5, 2011
[Melanoma: a new therapeutic era]G Berthod, K Homicsko, H Bouchaab, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Revue Medicale Suisse|July 12, 2008
[New developments in cancer immunotherapy]O Michielin, N Rufer, P Romero, et al.
Acta Neurochirurgica|February 14, 2004
The origin of brain metastases in patients with an undiagnosed primary tumourS Agazzi, S Pampallona, A Pica, et al.
British Journal of Cancer|August 31, 2006
CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase IIV Voelter, A Zouhair, H Vuilleumier, et al.
Journal of the National Cancer Institute|December 1, 1993
Sequential high-dose combination chemotherapy with granulocyte colony-stimulating factor and peripheral blood progenitor cells in patients with solid tumors: intensification limited by nonhematologic toxic effectsS Leyvraz, N Ketterer, P Vuichard, et al.
Psycho-Oncology|August 29, 2013
Psychodynamic interventions in cancer care I: psychometric results of a randomized controlled trialG Ludwig, S Krenz, C Zdrojewski, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administrationC Marzolini, L A Decosterd, F Shen, et al.
The New England Journal of Medicine|May 16, 1985
Association of Epstein-Barr virus with thymic carcinomaS Leyvraz, W Henle, A P Chahinian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomasS Leyvraz, M Zweifel, G Jundt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 6, 2007
Impact of family structure on long-term survivors of osteosarcomaA Bressoud, O Real del Sarte, S Stiefel, et al.
Revue Medicale Suisse|July 5, 2011
[Melanoma: a new therapeutic era]G Berthod, K Homicsko, H Bouchaab, et al.
Pageof 11